lump under nipple

[RockHard]

My cycle has been over about 5 weeks and I have a small lump under my nipple that wont go away, nolvadex hasn't taken it down and neither did clomid...any suggestions? I was taking 20mg of nolva a day, when I noticed it I took 40mg for a few days and it didn't do anything so now i'm at a loss.

[RockHard]

Footnote: I was using tren in my cycle, if that info helps at all.

[steroid500]

letrozole has been shown to reverse gyno in certain cases...worth a shot but since youre off cycle might mess your recovery up


dr. mordcai blau? Westchester Plastic Surgery, New York, NY Cosmetic Surgery by Dr. Blau, a Board Certified Plastic Surgeon

[prodigy06]

Tumah!!!!!!!

[Mulciber]

key is to knock it out when symptoms start before lumps form..once there odds are it will require surgery to get rid of it..

[Reinheart]

You could try using a-dex but i can't promise about the results...

[jasthace]

letrozols good for gyno caused on cycle{worked for me and many others},not so good apparently for gyno induced at puberty

[HDH]

Letro.

HDH

[RockHard]

it's so small i'm not all that worried about it...should I be? It's about a pee sized lump, can't notice it unless I press around on it.

[Mulciber]

pre existing gyno would make one more susceptible to high estrogen levels and it can be made worse by AAS that aromatize..

have been some studies that show nolvadex can be effective when dealing with pubertal gynecomastia. this one for example.


Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia.Lawrence SE, Faught KA, Vethamuthu J, Lawson ML.
Department of Pediatrics, University of Ottawa, Ontario, Canada. slawrence@cheo.on.ca

OBJECTIVES: To assess the efficacy of the anti-estrogens tamoxifen and raloxifen in the medical management of persistent pubertal gynecomastia. STUDY DESIGN: Retrospective chart review of 38 consecutive patients with persistent pubertal gynecomastia who presented to a pediatric endocrinology clinic. Patients received reassurance alone or a 3- to 9-month course of an estrogen receptor modifier (tamoxifen or raloxifene). RESULTS: Mean (SD) age of treated subjects was 14.6 (1.5) years with gynecomastia duration of 28.3 (16.4) months. Mean reduction in breast nodule diameter was 2.1 cm (95% CI 1.7, 2.7, P <.0001) after treatment with tamoxifen and 2.5 cm (95% CI 1.7, 3.3, P <.0001) with raloxifene. Some improvement was seen in 86% of patients receiving tamoxifen and in 91% receiving raloxifene, but a greater proportion had a significant decrease (>50%) with raloxifene (86%) than tamoxifen (41%). No side effects were seen in any patients. CONCLUSION: Inhibition of estrogen receptor action in the breast appears to be safe and effective in reducing persistent pubertal gynecomastia, with a better response to raloxifene than to tamoxifen. Further study is required to determine that this is truly a treatment effect.